A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine (Q33852864)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine |
scientific article |
Statements
1 reference
A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine (English)
1 reference
Laura Q Chow
Austin Pantel
Mara Roth
Leslie N Anderson
Alan Failor
Robert Doot
29 June 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference